TEL AVIV, Israel, Nov. 25, 2014 /PRNewswire/ -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today its results for the third quarter of 2014.

Three months ended September 30, 2014 compared to corresponding period in 2013

The Company's loss for the three months period ended September 30, 2014 ("Q3 2014") amounted to NIS 32 million.

Consolidated income, revenues and gain for Q3 2014 amounted to NIS 318 million (US$ 86 million) compared to NIS 120 million in the corresponding period in 2013 ("Q3 2013").

  • Revenues from sale of commercial centers increased in Q3 2014 to NIS 196 (US$ 53 million) compared to NIS 9 million in Q3 2013. Such amount in Q3 2014 is attributable to the sale of commercial centers by our 62% subsidiary Plaza Centers N.V. ("PC") in Serbia and sale of plot in Romania.

  • Rental income from commercial centers amounted to NIS 28 million (US$ 8 million) in Q3 2014 and in Q3 2013.

  • Cost of commercial centers increased in Q3 2014 to NIS 217 million (US$ 59 million) compared to NIS 39 million in Q3 2013. The increase is mainly attributable to (i) cost of commercial centers and plots sold by PC during Q3 2014 in the amount of NIS 198 million (US$ 54 million) compared to NIS 10 million in Q3 2013 offset by: (ii) decrease in PC's general and administrative expenses as a result of efficiency measures taken by PC during 2014.

  • Revenues from hotels operation and management increased in Q3 2014 to NIS 49 million (US$ 13 million) compared to NIS 47 million in Q3 2013.

  • Costs and expenses of hotels operation and management increased in Q3 2014 to NIS 42 million (US$ 11 million) compared to NIS 41 million in Q3 2013.

  • Revenues from fashion merchandise decreased in Q3 2014 to NIS 33 million (US$ 9 million) compared to NIS 36 million in Q3 2013. The decrease is attributable to the Israeli military operation in Gaza during Q3 and to the closing of three Mango stores compared to the opening of two new stores.

  • Cost of fashion retail increased in Q3 2014 to NIS 37 million (US$ 10 million) compared to NIS 35 million in Q3 2013.

  • Gain from change of shareholding in investees amounted to NIS 11 million (US$ 3 million) in Q3 2014 compared to nil in Q3 2013. This gain is attributable to decreased in our holdings in Gamida Cell Ltd, as a result of the consummation of an investment and option agreement with Novartis Pharmaceuticals Corporation.

  • General and administrative expenses amounted to NIS 8 million (US$ 2 million) in Q3 2014 compared to NIS 13 million in Q3 2013. The decrease in mainly attributable to the Company's arrangement costs in Q3 2013 as well as efficiency measures taken by the Company reducing the general and administrative costs in the Company's headquarters.

  • Share in losses of associated, net amounted to NIS 10 million (US$ 3 million) in Q3 2014 compared to NIS 288 in Q3 2013. Such losses in Q3 2014 are mainly attributable to the Company's medical device investments. The losses in Q3 2013 are mainly attributable to impairment of trading property by an associated company in India.

  • Financial expenses, net decreased in Q3 2014 to NIS 51 million (US$ 14 million) compared to NIS 188 million in Q3 2013. The decrease of NIS 137 million (US$ 37 million) is mainly attributable to the following:

    • A decrease in the amount of NIS 90 million (US$ 24 million) in non-cash expenses, as a result of changes in fair value of financial instruments (mainly PC's debentures and other derivatives), which are measured at fair value through profit and loss.

    • A decrease in interest expenses and CPI-linked borrowing expenses, net in the amount of NIS 67 million (US$ 18 million) mainly attributable to (i) decrease in the Company interest net mainly due to the lower level of the Company's Corporate debts following the consummation of the Company's debt restructuring; and (ii) a decrease in the Israeli consumer price index, to which the Company's and several of PC's notes are linked (0.29% in Q3 2014, compared to 1.29% in Q3 2013).

      Offset by:

    • An increase in the amount of NIS 20 million (US$ 5 million) in exchange rate losses mainly attributable to fluctuation in the exchange rate between the US$ and NIS with respect to the Company's loan from Israeli banks.

  • Other income, net in Q3 2014 amounted to NIS 15 million (US$ 4 million) compared to expenses in the amount of NIS 254 million in Q3 2013. The income in Q3 2014 is attributable to realization of revelation reserve to the profit and loss account as a result of the sale of Park Plaza shares held by the Company.

  • Loss before tax benefits amounted to NIS 33 million (US$ 9 million) in Q3 2014 compared to NIS 738 million in Q3 2013.

  • Tax benefits amounted to NIS 1 million (US$ 0.3 million) in Q3 2014 compared to NIS 29 million in Q3 2013.

  • Loss from continuing operations amounted to NIS 32 million (US$ 9 million) in Q3 2014 compared to NIS 709 million in Q3 2013.

  • Income from discontinued operations, net, amounted to nil in Q3 2014 compared to NIS 7 million in Q3 2013.

  • Loss for Q3 2014 amounted to NIS 32 million (US$ 9 million) (all attributed to the equity holders of the Company) compared to NIS 702 million in the corresponding period in 2013 (out of which NIS 523 million is attributed to the equity holders of the Company).

  • Shareholders' Equity as of September 30, 2014 amounted to NIS 861 million ($ 233 million) (out of which Shareholders' Equity in the amount of NIS 409 million ($ 111 million) is attributed to the controlling interest).

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, we operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the Consideration, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2013, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:
Ron Hadassi

Chairman of the Board of Directors
Acting CEO
Tel: +972-3-608-6048
ron@elbitimaging.com

 

 

ELBIT IMAGING LTD.

CONSOLIDATED BALANCE SHEETS



September 30

December 31

September 30


2 0 1 4

2 0 1 3

2 0 1 4




Convenience




translation


(in NIS thousands)

US$'000





Current Assets




Cash and cash equivalents

300,365

311,181

81,290

Short-term deposits and investments

94,534

82,157

25,584

Trade accounts receivables

90,219

38,498

24,416

Other receivables

38,963

47,330

10,545

Inventories

34,680

22,315

9,386

Trading property

-

192,867

-


558,761

694,348

151,221









Non-Current Assets




Trading property

1,962,048

2,380,039

531,001

Deposits, loans and other long-term balances

31,834

47,782

8,616

Investments in associates

331,874

333,440

89,817

Property, plant and equipment

1,056,371

1,108,835

285,891


3,382,127

3,870,096

915,325






3,940,888

4,564,444

1,066,546









Current Liabilities




Short-term credits

1,585,720

4,464,373

429,153

Suppliers and service providers

44,618

43,680

12,075

Payables and other credit balances

160,410

286,424

43,413


1,790,748

4,794,477

484,641





Non-Current liabilities




Borrowings

1,098,408

-

297,269

Other liabilities

103,264

93,466

27,947

Deferred taxes

87,033

85,131

23,554


1,288,705

178,597

348,770





Shareholders' Equity (Deficiency)




Attributable to equity holders of the Company

410,339

(1,032,637)

111,052

Non-controlling Interests

451,096

624,007

122,083


861,435

(408,630)

233,135






3,940,888

4,564,444

1,066,546





 

 

ELBIT IMAGING LTD.

CONSOLIDATED INCOME STATEMENTS



Nine months ended

Three months ended

Year ended

Nine months
ended


September 30

September 30

December 31,

September 30


2 0 1 4

2 0 1 3

2 0 1 4

2 0 1 3

2 0 1 3

2 0 1 4


(in NIS thousands)

Convenience







translation







US$'000

Income revenues and gains







Revenues







Revenues from sale of commercial centers

195,635

8,614

195,635

8,614

8,614

52,946

Revenues from hotel operation and management

146,253

149,364

49,505

46,794

202,791

39,581

Revenues from fashion merchandise

115,252

101,548

33,296

35,735

149,192

31,191

Total revenues

457,140

259,526

278,436

91,143

360,597

123,718








Gains and other







Rental income from Commercial centers

87,896

97,522

27,962

28,530

129,748

23,788








Gain from changes of shareholding in investees

11,301

-

11,301

-

-

3,058








Total gains

99,197

97,522

39,263

28,530

129,748

26,846








Total income revenues and gains

556,337

357,048

317,699

119,673

490,345

150,564















Expenses and losses







Hotels operations and management

127,548

133,701

42,280

41,235

179,137

34,519

Cost of fashion merchandise

113,805

99,343

36,704

34,575

142,417

30,800

Commercial centers

262,168

95,945

217,408

39,402

124,737

70,952

General and administrative expenses

25,383

43,825

7,836

13,059

60,643

6,869

Share in losses of associates, net

27,389

355,043

10,086

288,158

339,030

7,414

Financial expenses, net

246,948

330,157

51,213

187,535

401,900

66,833

Financial gain from debt restructuring

(1,610,111)

-

319

-

-

(435,752)

Write-down, charges and other (income) expenses, net

409,211

620,369

(14,983)

254,125

841,462

110,746


(397,659)

1,678,383

350,863

858,089

2,089,326

(107,619)















Profit (Loss) before income taxes

953,996

(1,321,335)

(33,164)

(738,416)

(1,598,981)

258,183

Tax income (benefits)

3,369

(30,809)

(1,062)

(29,242)

(31,937)

912

Profit (Loss) from continuing operations

950,627

(1,290,526)

(32,102)

(709,174)

(1,567,044)

257,271

Profit from discontinued operation, net

-

3,485

-

6,746

2,034

-

Profit (Loss)  for the period

950,627

(1,287,041)

(32,102)

(702,428)

(1,565,010)

257,271








Attributable to:














Equity holders of the Company

1,129,198

(955,378)

(31,711)

(522,789)

(1,155,645)

305,599

Non-controlling interest

(178,571)

(331,663)

(391)

(179,639)

(409,365)

(48,328)


950,627

(1,287,041)

(32,102)

(702,428)

(1,565,010)

257,271








 

 

ELBIT IMAGING LTD.

CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS



Nine months ended

Three months ended

Year ended

Nine months
ended


September 30

September 30

December 31,

September 30


2 0 1 4

2 0 1 3

2 0 1 4

2 0 1 3

2 0 1 3

2 0 1 4


(in NIS thousands)

Convenience







translation







US$'000















Profit (Loss) for the period

950,627

(1,287,041)

(32,102)

(702,428)

(1,565,010)

257,271








Other comprehensive income to be reclassified to profit or loss in subsequent periods:














Exchange differences arising from translation of foreign operations

6,355

(233,901)

12,792

(29,680)

(267,861)

1,719

Gain (loss) from cash flow hedge

(783)

4,193

(598)

24

4,439

(212)

Gain (loss) from available for sale investments

(11,868)

7,577

(17,147)

3,755

3,545

(3,212)


(6,296)

(222,131)

(4,953)

(25,901)

(259,877)

(1,705)

Items not to be reclassified to profit or loss in subsequent periods:







Additions during the period

(25)

-

5,887

-

27,700

(7)


(25)

-

5,887

-

27,700

(7)








Other Comprehensive income (loss)

(6,321)

(222,131)

934

(25,902)

(232,177)

(1,712)















Comprehensive income (loss)

944,306

(1,509,172)

(31,168)

(728,329)

(1,797,187)

255,559








Attributable to:







Equity holders of the Company

1,125,818

(1,112,545)

(33,024)

(540,042)

(1,328,500)

304,683

Non-controlling interest

(181,512)

(396,627)

1,856

(188,287)

(468,687)

(49,124)


944,306

(1,509,172)

(31,168)

(728,329)

(1,797,187)

255,559








 

 

ELBIT IMAGING LTD.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY



Share
capital

Share
premium

Other reserves
(*)

Revaluation
of property,
plant and
equipment

Stock-based
compensation
reserve

Foreign
currency
translation
reserve

Retained
earnings

Gross
amount

Treasury
stock

Attributable to
share-holders
of the
company

Non
Controlling
interest

Total
shareholders'
equity


(in thousand NIS)

Balance -
January 1, 2013

38,059

864,811

(191,698)

190,690

49,835

(553,627)

59,081

457,151

(168,521)

288,629

1,100,479

1,389,108

Loss  for the year

-

-

-

-

-

-

(1,155,645)

(1,155,645)

-

(1,155,645)

(409,365)

(1,565,010)

Other comprehensive income (loss)

-

-

7,985

11,593

-

(202,257)

9,740

(172,939)

-

(172,939)

(59,323)

(232,262)

Transaction with non-controlling interest

-

-

1,853

-

-

-

-

1,853

-

1,853

1,106

2,959

Reclassification of a derivative (options) following a change in terms

-

-

-

-

-

-

-

-

-

-

(11,819)

(11,819)

Exercise of options by employees

10

1,673

-

-

(1,683)

-

-

-

-

-

-

-

Expiration of options held by minority

-

4,804

-

-

-

-

-

4,804

-

4,804

(4,804)

-

Stock-based compensation expenses

-

-

-

-

660

-

-

660

-

660

7,734

8,394














Balance -
December  31, 2013

38,069

871,288

(181,862)

202,283

48,812

(755,886)

(1,086,820)

(864,116)

(168,521)

(1,032,637)

624,007

(408,630)














Profit (loss)  for the period







1,129,198

1,129,198


1,129,198

(178,571)

950,627

Other comprehensive income (loss)



(12,471)

(8,016)


9,116

7,991

(3,380)


(3,380)

(2,941)

(6,321)

Issuance of shares


314,220






314,220


314,220


314,220

Transaction with non-controlling interest



2,461





2,461


2,461

1,515

3,976

Treasury stock and old stock cancellation

(38,069)

(130,452)






(168,521)

168,521

-



Out of consolidation











2,277

2,277

Classification











1,604

1,604

Stock-based compensation expenses





477



477


477

3,205

3,682

Balance -
September 30, 2014

-

1,055,056

(191,872)

194,267

49,289

(746,770)

50,369

410,339

-

410,339

451,096

861,435














 (*)  includes transactions with non-controlling interest reserve and hedging reserve.

 

 

ELBIT IMAGING LTD.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY



Share
capital

Share
premium

Other
reserves
(*)

Revaluation
of property,
plant and
equipment

Stock-based
compensation
reserve

Foreign
currency
translation
reserve

Retained
earnings

Gross
amount

Treasury
stock

Attributable
to share-
holders of
the company

Non
Controlling
interest

Total
shareholder's
equity


Convenience translation, U.S.$'000

Balance -
January  1, 2014

10,303

235,802

(49,218)

54,745

13,210

(204,570)

(294,133)

(233,861)

(45,608)

(279,469)

168,879

(110,590)

Profit (loss)  for the period







305,602

305,602


305,602

(48,328)

257,274

Other comprehensive income (loss)



(3,375)

(2,169)


2,467

2,163

(915)


(915)

(796)

(1,711)

Issuance of shares


85,039






85,039


85,039

0

85,039

Transaction with non-controlling interest



666





666


666

410

1,076

Treasury stock and old stock
cancellation

(10,303)

(35,305)






(45,608)

45,608



-

Out of consolidation








-



616

616

Classification











434

434

Stock-based compensation expenses





129



129


129

867

996

Balance -
September 30, 2014

-

285,536

(51,927)

52,576

13,339

(202,103)

13,632

111,052

-

111,052

122,083

233,135














(*)  includes transactions with non-controlling interest reserve and hedging reserve.

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/elbit-imaging-ltd-announces-third-quarter-results-for-2014-300001193.html

SOURCE Elbit Imaging

Copyright 2014 PR Newswire

Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Elbit Imaging (CE) Charts.
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Elbit Imaging (CE) Charts.